Obstacles to prompt and effective malaria treatment lead to low community-coverage in two rural districts of Tanzania.
BACKGROUND
Malaria is still a leading child killer in sub-Saharan Africa. Yet, access to prompt and effective malaria treatment, a mainstay of any malaria control strategy, is sub-optimal in many settings. Little is known about obstacles to treatment and community-effectiveness of case-management strategies. This research quantified treatment seeking behaviour and access to treatment in a highly endemic rural Tanzanian community. The aim was to provide a better understanding of obstacles to treatment access in order to develop practical and cost-effective interventions.


METHODS
We conducted community-based treatment-seeking surveys including 226 recent fever episodes in 2004 and 2005. The local Demographic Surveillance System provided additional household information. A census of drug retailers and health facilities provided data on availability and location of treatment sources.


RESULTS
After intensive health education, the biomedical concept of malaria has largely been adopted by the community. 87.5% (78.2-93.8) of the fever cases in children and 80.7% (68.1-90.0) in adults were treated with one of the recommended antimalarials (at the time SP, amodiaquine or quinine). However, only 22.5% (13.9-33.2) of the children and 10.5% (4.0-21.5) of the adults received prompt and appropriate antimalarial treatment. Health facility attendance increased the odds of receiving an antimalarial (OR = 7.7) but did not have an influence on correct dosage. The exemption system for under-fives in public health facilities was not functioning and drug expenditures for children were as high in health facilities as with private retailers.


CONCLUSIONS
A clear preference for modern medicine was reflected in the frequent use of antimalarials. Yet, quality of case-management was far from satisfactory as was the functioning of the exemption mechanism for the main risk group. Private drug retailers played a central role by complementing existing formal health services in delivering antimalarial treatment. Health system factors like these need to be tackled urgently in order to translate the high efficacy of newly introduced artemisinin-based combination therapy (ACT) into equitable community-effectiveness and health-impact.
Hetzel
Manuel W
MW
Dept, of Public Health and Epidemiology, Swiss Tropical Institute, PO Box, CH-4002 Basel, Switzerland. manuel.hetzel@unibas.ch
Obrist
Brigit
B
Lengeler
Christian
C
Msechu
June J
JJ
Nathan
Rose
R
Dillip
Angel
A
Makemba
Ahmed M
AM
Mshana
Christopher
C
Schulze
Alexander
A
Mshinda
Hassan
H
D000293:Adolescent; D000328:Adult; D000704:Analysis of Variance; D000962:Antimalarials / Q000191:economics / Q000627:therapeutic use; D002648:Child; D003430:Cross-Sectional Studies; D005260:Female; D005334:Fever / Q000209:etiology / Q000628:therapy*; D019538:Health Care Surveys; D006801:Humans; D016015:Logistic Models; D008288:Malaria / Q000628:therapy*; D008297:Male; D010342:Patient Acceptance of Health Care / Q000523:psychology / Q000706:statistics & numerical data; D011203:Poverty; D019035:Rural Health Services / Q000706:statistics & numerical data* / Q000600:supply & distribution; D013636:Tanzania
D000962:Antimalarials
Trop Med Int Health. 2004 Apr;9(4):451-60
15078263
Trop Med Int Health. 1996 Jun;1(3):305-13
8673832
Ann Trop Paediatr. 2005 Jun;25(2):91-100
15949197
Malar J. 2004 Jul 28;3:27
15282029
Lancet. 2004 Sep 4-10;364(9437):900-6
15351199
Soc Sci Med. 2002 Aug;55(3):403-13
12144148
Malar J. 2006 Nov 14;5:109
17105662
J Biosoc Sci. 2002 Jan;34(1):109-31
11814209
JAMA. 2007 May 23;297(20):2281-4
17519417
Trans R Soc Trop Med Hyg. 1999 May-Jun;93(3):225-31
10492745
Trop Med Int Health. 2003 Sep;8(9):767-74
12950662
Lancet. 2005 Sep 17-23;366(9490):1026-35
16168785
Health Policy Plan. 2006 Jul;21(4):326-8
16672294
Health Policy Plan. 2002 Dec;17(4):333-44
12424205
Lancet. 2003 Feb 15;361(9357):561-6
12598141
Soc Sci Med. 1996 Apr;42(7):1057-67
8730911
Malar J. 2005 Nov 18;4:55
16297234
Malar J. 2007 Jun 29;6:83
17603898
Trop Med Int Health. 2007 Jan;12(1):52-61
17207148
Bull World Health Organ. 2000;78(11):1352-7
11143196
Malar J. 2008 Jan 09;7:7
18184430
Trop Med Int Health. 2006 Mar;11(3):299-313
16553910
Trop Med Int Health. 2003 Dec;8(12):1143-52
14641851
Malar J. 2006 Apr 24;5:33
16635265
PLoS Med. 2007 Oct;4(10):1584-8
17958467
Trends Parasitol. 2004 Dec;20(12):597-603
15522670
Bull World Health Organ. 2002;80(10):790-6
12471399
BMC Infect Dis. 2007 Oct 25;7:121
17961211
World Health Organ Tech Rep Ser. 1993;839:1-57
8284937
Trop Med Int Health. 2001 Jun;6(6):423-8
11422955
Trop Med Int Health. 2001 Aug;6(8):614-23
11555427
Anthropol Med. 1998 Apr;5(1):43-61
26868738